Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany

INTRODUCTION: Multiple myeloma remains an incurable plasma cell malignancy which, despite improvements in overall survival over the last decade, is characterized by recurrent relapse and is associated with a poor prognosis. This study investigates the use of novel agents in current real-world clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinmetz, H. Tilman, Singh, Moushmi, Milce, Joseph, Haidar, Mohamad, Rieth, Achim, Lebioda, Andrea, Kohnke, Jörn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918129/
https://www.ncbi.nlm.nih.gov/pubmed/35034310
http://dx.doi.org/10.1007/s12325-021-02022-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918129/
https://www.ncbi.nlm.nih.gov/pubmed/35034310
http://dx.doi.org/10.1007/s12325-021-02022-z

Ejemplares similares